Biotech CEO Resignation/Changes Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech CEO Resignation/Changes

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (4)	1/26/2004 3:31:20 PM
From: keokalani'nui	Read Replies (1) of 6

From the whacked-out (creepy-type) dept., here's a PR for posterity. American Bio Medica says CEO removed from post Thursday January 22, 5:01 pm ET LOS ANGELES, Jan 22 (Reuters) - American Bio Medica Corp. (NasdaqSC:ABMC - News), a biotechnology company, on Thursday said it had removed its chief executive as part of a shake-up intended to meet earnings targets for the current quarter and all of 2004. In a statement, Kinderhook, New York-based American Bio Medica said Donal Carroll, who had been CEO since October, had been "removed" from his executive position but would remain on the board of directors. Carroll was not immediately available for comment. "Immediate action was necessary to insure our objective of continued sales and earnings growth in this quarter as well as the remainder of 2004," said Edmund Jaskiewicz, president and a member of the executive committee of the board.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next